Magicare AI

Magicare AI is a US-based company specializing in an AI-native operating system tailored for post-acute care, enhancing operational efficiency and patient outcomes through streamlined admissions and coordination processes. Founded in 2024 in New York, US, Magicare AI focuses on optimizing post-acute care operations. The company is led by CEO Daniel Schoenbrun. The company successfully raised USD 3.

6 mn in pre-seed funding from Mana Ventures in April 2026, marking its first investment round. The firm's operations pivot around a core platform designed to facilitate healthcare admissions for various organizations, including nursing homes and rehabilitation facilities. Magicare offers an AI-native operating system specifically designed for post-acute care settings. The core product focuses on optimizing the admissions process by centralizing referrals, automating the extraction of key details, and facilitating coordination among healthcare teams in a streamlined manner.

This platform addresses critical challenges such as reducing operational friction associated with admissions, enhancing patient outcomes, and improving team efficiency. Key features include a mobile and web-based application for real-time referral intelligence, communication tools for discharge planners, and integrated analytics for monitoring bed availability and patient counts. Magicare primarily serves healthcare organizations, including nursing homes and rehabilitation facilities, across the United States, positioning itself to cater to a broad range of clients in the healthcare sector. Magicare generates revenue through a subscription-based model, charging clients a monthly fee of USD 87 for access to its comprehensive admissions and coordination platform.

This pricing structure encompasses all essential features, including referral aggregation, scoring recommendations, and live census monitoring, designed to enhance operational efficiency for healthcare organizations. Clients engage in B2B transactions, where healthcare facilities directly subscribe to the platform to improve their admission processes and patient management capabilities. By providing a centralized solution, Magicare fosters significant improvements in workflow and efficiency for its users, thus solidifying its value proposition within the post-acute care market. In April 2026, Magicare AI raised USD 3.

6 mn in pre-seed funding from Mana Ventures, which will be utilized to scale a suite of AI agents purpose-built for post-acute operators. The company plans to expand its offerings by developing new products aimed at enhancing care coordination and operational efficiency. Specific geographic expansion plans have not been detailed but are expected to follow the upcoming product launches.